Bioreversible protection of nucleoside diphosphates
HJ Jessen, T Schulz, J Balzarini…
Index: Jessen, Henning Jacob; Schulz, Tilmann; Balzarini, Jan; Meier, Chris Angewandte Chemie - International Edition, 2008 , vol. 47, # 45 p. 8719 - 8722
Full Text: HTML
Citation Number: 56
Abstract
Nucleoside analogues are applied widely in antiviral and antitumor therapy. A severe limitation of these compounds is that they must undergo biotransformation into the corresponding active nucleoside triphosphates (NTPs) by the stepwise addition of phosphate groups by kinases.[1] If this activation proceeds insufficiently, the antiviral or antitumor activity of the nucleoside analogues can possibly be enhanced by using ...
Related Articles:
[Zakhari, Joseph S.; Kinoyama, Isao; Hixon, Mark S.; Di Mola, Antonia; Globisch, Daniel; Janda, Kim D. Bioorganic and Medicinal Chemistry, 2011 , vol. 19, # 21 p. 6203 - 6209]
[Iyer, Radhakrishnan P.; Yu, Dong; Devlin, Theresa; Ho, Nan-Hui; Agrawal, Sudhir Bioorganic and Medicinal Chemistry Letters, 1996 , vol. 6, # 16 p. 1917 - 1922]
[Zakhari, Joseph S.; Kinoyama, Isao; Hixon, Mark S.; Di Mola, Antonia; Globisch, Daniel; Janda, Kim D. Bioorganic and Medicinal Chemistry, 2011 , vol. 19, # 21 p. 6203 - 6209]
[Iyer, Radhakrishnan P.; Yu, Dong; Devlin, Theresa; Ho, Nan-Hui; Agrawal, Sudhir Bioorganic and Medicinal Chemistry Letters, 1996 , vol. 6, # 16 p. 1917 - 1922]
[Iyer, Radhakrishnan P.; Yu, Dong; Devlin, Theresa; Ho, Nan-Hui; Agrawal, Sudhir Bioorganic and Medicinal Chemistry Letters, 1996 , vol. 6, # 16 p. 1917 - 1922]